1192 related articles for article (PubMed ID: 26947328)
21. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ
Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202
[TBL] [Abstract][Full Text] [Related]
22. Randomized double-blind trial of sulindac and etodolac to eradicate aberrant crypt foci and to prevent sporadic colorectal polyps.
Takayama T; Nagashima H; Maeda M; Nojiri S; Hirayama M; Nakano Y; Takahashi Y; Sato Y; Sekikawa H; Mori M; Sonoda T; Kimura T; Kato J; Niitsu Y
Clin Cancer Res; 2011 Jun; 17(11):3803-11. PubMed ID: 21385928
[TBL] [Abstract][Full Text] [Related]
23. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial.
Yoshino T; Mizunuma N; Yamazaki K; Nishina T; Komatsu Y; Baba H; Tsuji A; Yamaguchi K; Muro K; Sugimoto N; Tsuji Y; Moriwaki T; Esaki T; Hamada C; Tanase T; Ohtsu A
Lancet Oncol; 2012 Oct; 13(10):993-1001. PubMed ID: 22951287
[TBL] [Abstract][Full Text] [Related]
24. High-risk metachronous polyps are more frequent in patients with traditional serrated adenomas than in patients with conventional adenomas: a multicenter prospective study.
Yoon JY; Kim HT; Hong SP; Kim HG; Kim JO; Yang DH; Park DI; Park SJ; Kim HS; Keum B; Park CH; Eun CS; Lee SH; Baek IH; Chang DK; Kim TI
Gastrointest Endosc; 2015 Dec; 82(6):1087-93.e3. PubMed ID: 26117178
[TBL] [Abstract][Full Text] [Related]
25. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.
Anderson JC; Baron JA; Ahnen DJ; Barry EL; Bostick RM; Burke CA; Bresalier RS; Church TR; Cole BF; Cruz-Correa M; Kim AS; Mott LA; Sandler RS; Robertson DJ
Gastroenterology; 2017 Jun; 152(8):1933-1943.e5. PubMed ID: 28219690
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2.
Liljegren A; Barker G; Elliott F; Bertario L; Bisgaard ML; Eccles D; Evans G; Macrae F; Maher E; Lindblom A; Rotstein S; Nilsson B; Mecklin JP; Möslein G; Jass J; Fodde R; Mathers J; Burn J; Bishop DT
J Clin Oncol; 2008 Jul; 26(20):3434-9. PubMed ID: 18612159
[TBL] [Abstract][Full Text] [Related]
27. Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial.
Pommergaard HC; Burcharth J; Rosenberg J; Raskov H
Gastroenterology; 2016 Jan; 150(1):114-122.e4. PubMed ID: 26404953
[TBL] [Abstract][Full Text] [Related]
28. A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.
Baron JA; Sandler RS; Bresalier RS; Quan H; Riddell R; Lanas A; Bolognese JA; Oxenius B; Horgan K; Loftus S; Morton DG;
Gastroenterology; 2006 Dec; 131(6):1674-82. PubMed ID: 17087947
[TBL] [Abstract][Full Text] [Related]
29. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
Benamouzig R; Uzzan B; Deyra J; Martin A; Girard B; Little J; Chaussade S;
Gut; 2012 Feb; 61(2):255-61. PubMed ID: 21890814
[TBL] [Abstract][Full Text] [Related]
30. A monotonous population of elongated cells (MPECs) in colorectal adenoma indicates a high risk of metachronous cancer.
Soreide K; Buter TC; Janssen EA; van Diermen B; Baak JP
Am J Surg Pathol; 2006 Sep; 30(9):1120-9. PubMed ID: 16931957
[TBL] [Abstract][Full Text] [Related]
31. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.
Sandler RS; Halabi S; Baron JA; Budinger S; Paskett E; Keresztes R; Petrelli N; Pipas JM; Karp DD; Loprinzi CL; Steinbach G; Schilsky R
N Engl J Med; 2003 Mar; 348(10):883-90. PubMed ID: 12621132
[TBL] [Abstract][Full Text] [Related]
32. Association of small versus diminutive adenomas and the risk for metachronous advanced adenomas: data from the New Hampshire Colonoscopy Registry.
Anderson JC; Rex DK; Robinson C; Butterly LF
Gastrointest Endosc; 2019 Sep; 90(3):495-501. PubMed ID: 31125546
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of metachronous colorectal adenomas found during long-term follow-up: analysis of four subsequent generations of adenoma recurrence.
Nusko G; Hahn EG; Mansmann U
Scand J Gastroenterol; 2009; 44(6):736-44. PubMed ID: 19277927
[TBL] [Abstract][Full Text] [Related]
34. Green tea extracts for the prevention of metachronous colorectal polyps among patients who underwent endoscopic removal of colorectal adenomas: A randomized clinical trial.
Shin CM; Lee DH; Seo AY; Lee HJ; Kim SB; Son WC; Kim YK; Lee SJ; Park SH; Kim N; Park YS; Yoon H
Clin Nutr; 2018 Apr; 37(2):452-458. PubMed ID: 28209333
[TBL] [Abstract][Full Text] [Related]
35. Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial.
Meyskens FL; McLaren CE; Pelot D; Fujikawa-Brooks S; Carpenter PM; Hawk E; Kelloff G; Lawson MJ; Kidao J; McCracken J; Albers CG; Ahnen DJ; Turgeon DK; Goldschmid S; Lance P; Hagedorn CH; Gillen DL; Gerner EW
Cancer Prev Res (Phila); 2008 Jun; 1(1):32-8. PubMed ID: 18841250
[TBL] [Abstract][Full Text] [Related]
36. Total polyp number may be more important than size and histology of polyps for prediction of metachronous high-risk colorectal neoplasms.
Yoon H; Shin CM; Park YS; Kim N; Lee DH
BMC Gastroenterol; 2022 Mar; 22(1):91. PubMed ID: 35236287
[TBL] [Abstract][Full Text] [Related]
37. A randomized controlled trial of eicosapentaenoic acid and/or aspirin for colorectal adenoma prevention during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme (The seAFOod Polyp Prevention Trial): study protocol for a randomized controlled trial.
Hull MA; Sandell AC; Montgomery AA; Logan RF; Clifford GM; Rees CJ; Loadman PM; Whitham D
Trials; 2013 Jul; 14():237. PubMed ID: 23895505
[TBL] [Abstract][Full Text] [Related]
38. Young adults and metachronous neoplasia: risks for future advanced adenomas and large serrated polyps compared with older adults.
Anderson JC; Robinson CM; Butterly LF
Gastrointest Endosc; 2020 Mar; 91(3):669-675. PubMed ID: 31759925
[TBL] [Abstract][Full Text] [Related]
39. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.
Baron JA; Beach M; Mandel JS; van Stolk RU; Haile RW; Sandler RS; Rothstein R; Summers RW; Snover DC; Beck GJ; Bond JH; Greenberg ER
N Engl J Med; 1999 Jan; 340(2):101-7. PubMed ID: 9887161
[TBL] [Abstract][Full Text] [Related]
40. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.
Hurvitz SA; Andre F; Jiang Z; Shao Z; Mano MS; Neciosup SP; Tseng LM; Zhang Q; Shen K; Liu D; Dreosti LM; Burris HA; Toi M; Buyse ME; Cabaribere D; Lindsay MA; Rao S; Pacaud LB; Taran T; Slamon D
Lancet Oncol; 2015 Jul; 16(7):816-29. PubMed ID: 26092818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
